ロード中...
Retinopathy of Prematurity: Evolving Treatment with anti-Vascular Endothelial Growth Factor
PURPOSE: To discuss the evolution in retinopathy of prematurity (ROP) since its first description as retrolental fibroplasia in the US, including the changes in the understanding of pathophysiology; methods of diagnosis; destructive, anti-VEGF, and supportive treatments; and differences in ROP manif...
保存先:
| 出版年: | Am J Ophthalmol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529736/ https://ncbi.nlm.nih.gov/pubmed/32450064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2020.05.025 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|